News – Page 96 – Endpoints News

Novo says its CB1 drug helped shed weight, but efficacy and safety questions remain

7 months ago

Novo axes Phase 2 of Forma-acquired drug in myelodysplastic syndromes

7 months ago

Lexicon's president to step down as decision date looms; Sarepta welcomes Lilly, GSK vet to board

7 months ago

Gilead's Kite uncouples from Fosun in China as Yescarta faces coverage obstacles

7 months ago

Sanofi's BTK inhibitor again slows MS progression, but liver enzymes continue to be tricky

7 months ago

Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend

7 months ago

House committee advances PRV reauthorization, but timing on final passage remains 'murky'

7 months ago

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

7 months ago

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

7 months ago

BioCentriq names ex-Resilient exec as new CEO; Sanofi, AstraZeneca boost Beyfortus production

7 months ago

Fertility benefits giant Progyny loses client that accounted for 13% of its revenue

7 months ago

Edgewise’s stock surges as heart drug passes early safety test

7 months ago

Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

7 months ago

4DMT's gene therapy reduced need for standard-of-care injections to treat age-associated vision loss

7 months ago

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

7 months ago

Sheryl Sandberg-backed Cercle raises $6M seed round with future plans to sell its services to pharma

7 months ago

FDA rejects Vanda’s treatment for digestion condition, company rebukes agency's actions

7 months ago

Stem cell startup spun out of George Church’s lab raises $75M

7 months ago

Tang Capital’s Concentra bids for Singular Genomics days after Deerfield offer

7 months ago

Upstream Bio files for IPO in sign of life for biotech public offerings

7 months ago

FDA approves AstraZeneca’s asthma medication Fasenra to treat rare autoimmune condition

7 months ago

Here's what today's Fed rate cut means for biotech, pharma and venture capital

7 months ago

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

7 months ago

Keytruda adds new FDA approval for a rare form of mesothelioma

7 months ago

First page Previous page 93 94 959697 98 99 Next page Last page